{"code":"J70.4","type":"code","title":"Drug-induced interstitial lung disorders, unspecified","codeAlso":[],"includes":[],"modern_v":"official26","codeFirst":[],"excludes1":["interstitial pneumonia NOS (J84.9)","lymphoid interstitial pneumonia (J84.2)"],"excludes2":["asthma (J45.-)","malignant neoplasm of bronchus and lung (C34.-)"],"isBillable":true,"fyEffectivity":{"fy2026":true,"fy2027":true},"inclusionTerms":[],"useAdditionalCode":["code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)"],"clinicalDefinition":"Drug-induced interstitial lung disorders, unspecified is a billable ICD-10-CM diagnosis code (J70.4). Excludes1 (not coded here): interstitial pneumonia NOS (J84.9); lymphoid interstitial pneumonia (J84.2). Excludes2 (not included here): asthma (J45.-); malignant neoplasm of bronchus and lung (C34.-). Use additional code: code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5).","officialDefinition":"Drug-induced interstitial lung disorders, unspecified is a billable ICD-10-CM diagnosis code (J70.4). Excludes1 (not coded here): interstitial pneumonia NOS (J84.9); lymphoid interstitial pneumonia (J84.2). Excludes2 (not included here): asthma (J45.-); malignant neoplasm of bronchus and lung (C34.-). Use additional code: code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5).","seventhCharacterInstructions":[],"workflowProtocols":[],"guidelines":{"whenToUse":[],"whenNotToUse":[],"commonBillingMistakes":[],"codeComparisons":[],"documentationChecklist":[]},"domainLandscape":{"summary":"Primary diagnostic domain and clinical landscape evaluation.","keyCategories":[],"diagnosticContinuum":"Progression continuum from acute presentation to resolution."},"children":[],"hierarchy":[],"relatedCodes":[],"relevantCPTCodes":[],"documentationTips":[],"caseStudies":[],"description":"","overview":""}